CompletedNCT02789982
Propranolol-Based Memory Therapy After the Paris Attacks
About this title
Read the official source — NCT02789982Medication studyAges 16+FrancePTSD
Understand this study
Who was this study for?
Listed age limits: from 16 years.
- Listed locations
- Créteil and 19 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateStarted: May 27, 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 364
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Sponsor type
- Unknown or unclear
- Study type
- Behavioral
- Intervention type
- Psychotherapy / behavioral intervention, Medication / drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- Over 16 Years
- Official registry ID
- NCT02789982
- Official title
Show the full official title
Using Reconsolidation Blockade to Treat Trauma Related Disorders After Paris Attacks: an Effectiveness Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Créteil, France · Garches, France · Issy-les-Moulineaux, France
11 more locations
- Jossigny, France
- Le Kremlin-Bicêtre, France
- Lille, France
- Meaux, France
- Nice, France
- Paris, France
- Poitiers, France
- Saint-Denis, France
- Saint-Maurice, France
- Sotteville-lès-Rouen, France
- Fort-de-France, Martinique
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Assistance Publique - Hôpitaux de Paris.
Did this study involve medication?
Yes. The study involved medication, including β-adrenergic blocker propranolol.
Who was this study for?
Listed age limits: from 16 years.
